165 related articles for article (PubMed ID: 25252196)
21. Nicotine- and cocaine-triggered methamphetamine reinstatement in female and male Sprague-Dawley rats.
Pittenger ST; Chou S; Barrett ST; Catalano I; Lydiatt M; Bevins RA
Pharmacol Biochem Behav; 2017 Aug; 159():69-75. PubMed ID: 28712749
[TBL] [Abstract][Full Text] [Related]
22. The effects of varenicline on methamphetamine self-administration and drug-primed reinstatement in female rats.
Pittenger ST; Barrett ST; Chou S; Bevins RA
Behav Brain Res; 2016 Mar; 300():150-9. PubMed ID: 26638833
[TBL] [Abstract][Full Text] [Related]
23. A comparison of amphetamine- and methamphetamine-induced locomotor activity in rats: evidence for qualitative differences in behavior.
Hall DA; Stanis JJ; Marquez Avila H; Gulley JM
Psychopharmacology (Berl); 2008 Jan; 195(4):469-78. PubMed ID: 17874316
[TBL] [Abstract][Full Text] [Related]
24. Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence.
Baumann MH; Phillips JM; Ayestas MA; Ali SF; Rice KC; Rothman RB
Ann N Y Acad Sci; 2002 Jun; 965():92-108. PubMed ID: 12105088
[TBL] [Abstract][Full Text] [Related]
25. Neonatal exposure to lipopolysaccharide enhances methamphetamine-induced reinstated behavioral sensitization in adult rats.
Tien LT; Cai Z; Rhodes PG; Fan LW
Behav Brain Res; 2011 Oct; 224(1):166-73. PubMed ID: 21669234
[TBL] [Abstract][Full Text] [Related]
26. Vulnerability to (+)-methamphetamine effects and the relationship to drug disposition in pregnant rats during chronic infusion.
White SJ; Laurenzana EM; Gentry WB; Hendrickson HP; Williams DK; Ward KW; Owens SM
Toxicol Sci; 2009 Sep; 111(1):27-36. PubMed ID: 19520673
[TBL] [Abstract][Full Text] [Related]
27. The effects of varenicline on methamphetamine self-administration and drug-primed reinstatement in male rats.
Pittenger ST; Barrett ST; Chou S; Bevins RA
Behav Brain Res; 2017 Mar; 320():195-199. PubMed ID: 27939341
[TBL] [Abstract][Full Text] [Related]
28. Customizing monoclonal antibodies for the treatment of methamphetamine abuse: current and future applications.
Peterson EC; Gentry WB; Owens SM
Adv Pharmacol; 2014; 69():107-27. PubMed ID: 24484976
[TBL] [Abstract][Full Text] [Related]
29. Chronic treatment with curcumin enhances methamphetamine locomotor sensitization and cue-induced reinstatement of methamphetamine self-administration.
Zhao C; Lou Z; Zimmer B; Yu Z; Li P; Ma B; Sun Y; Huang K; Zhou W; Liu Y
Pharmacol Biochem Behav; 2012 Oct; 102(4):555-61. PubMed ID: 22750063
[TBL] [Abstract][Full Text] [Related]
30. Anti-phencyclidine monoclonal antibody binding capacity is not the only determinant of effectiveness, disproving the concept that antibody capacity is easily surmounted.
Pitas G; Laurenzana EM; Williams DK; Owens SM; Gentry WB
Drug Metab Dispos; 2006 Jun; 34(6):906-12. PubMed ID: 16507651
[TBL] [Abstract][Full Text] [Related]
31. Interactions between iboga agents and methamphetamine sensitization: studies of locomotion and stereotypy in rats.
Szumlinski KK; Balogun MY; Maisonneuve IM; Glick SD
Psychopharmacology (Berl); 2000 Aug; 151(2-3):234-41. PubMed ID: 10972470
[TBL] [Abstract][Full Text] [Related]
32. Differential neurochemical consequences of an escalating dose-binge regimen followed by single-day multiple-dose methamphetamine challenges.
Graham DL; Noailles PA; Cadet JL
J Neurochem; 2008 Jun; 105(5):1873-85. PubMed ID: 18248616
[TBL] [Abstract][Full Text] [Related]
33. Prenatal lead exposure enhances methamphetamine sensitization in rats.
Clifford PS; Hart N; Thompson J; Buckman S; Wellman PJ; Bratton GR; Nation JR
Pharmacol Biochem Behav; 2009 Aug; 93(2):165-9. PubMed ID: 19433104
[TBL] [Abstract][Full Text] [Related]
34. Disposition of methamphetamine and its metabolite amphetamine in brain and other tissues in rats after intravenous administration.
Rivière GJ; Gentry WB; Owens SM
J Pharmacol Exp Ther; 2000 Mar; 292(3):1042-7. PubMed ID: 10688621
[TBL] [Abstract][Full Text] [Related]
35. Effect of acute and chronic administration of methamphetamine on activator protein-1 binding activities in the rat brain regions.
Akiyama K; Ishihara T; Kashihara K
Ann N Y Acad Sci; 1996 Oct; 801():13-28. PubMed ID: 8959020
[TBL] [Abstract][Full Text] [Related]
36. The Development and Characterization of an scFv-Fc Fusion-Based Gene Therapy to Reduce the Psychostimulant Effects of Methamphetamine Abuse.
Hay CE; Ewing LE; Hambuchen MD; Zintner SM; Small JC; Bolden CT; Fantegrossi WE; Margaritis P; Owens SM; Peterson EC
J Pharmacol Exp Ther; 2020 Jul; 374(1):16-23. PubMed ID: 32245884
[TBL] [Abstract][Full Text] [Related]
37. The effect of VMAT2 inhibitor GZ-793A on the reinstatement of methamphetamine-seeking in rats.
Alvers KM; Beckmann JS; Zheng G; Crooks PA; Dwoskin LP; Bardo MT
Psychopharmacology (Berl); 2012 Nov; 224(2):255-62. PubMed ID: 22638813
[TBL] [Abstract][Full Text] [Related]
38. PEGylation of a High-Affinity Anti-(+)Methamphetamine Single Chain Antibody Fragment Extends Functional Half-Life by Reducing Clearance.
Reichard EE; Nanaware-Kharade N; Gonzalez GA; Thakkar S; Owens SM; Peterson EC
Pharm Res; 2016 Dec; 33(12):2954-2966. PubMed ID: 27620175
[TBL] [Abstract][Full Text] [Related]
39. Generation of anti-(+)methamphetamine antibodies is not impeded by (+)methamphetamine administration during active immunization of rats.
Byrnes-Blake KA; Carroll FI; Abraham P; Owens SM
Int Immunopharmacol; 2001 Feb; 1(2):329-38. PubMed ID: 11360933
[TBL] [Abstract][Full Text] [Related]
40. Co-administration of naloxone and dexmedetomidine to simultaneously reverse acute effects of fentanyl and methamphetamine in rats.
Tackett WR; Yalakala J; Hambuchen MD
Drug Alcohol Depend; 2024 Jun; 259():111301. PubMed ID: 38640863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
